Colistin-induced acquired Bartter-like syndrome: an unusual cause of meltdown.


Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
05 Feb 2020
Historique:
entrez: 8 2 2020
pubmed: 8 2 2020
medline: 8 10 2020
Statut: epublish

Résumé

Colistin-induced nephrotoxicity is commonly associated with elevation of serum creatinine level or a reduction of urine output. Uncommonly, tubulopathy associated with colistin has been reported. Here we present a unique case of a 46-year-old man who developed polyuria, hypokalaemia, hypocalcaemia, hypomagnesemia and metabolic alkalosis after 3 days of therapy with intravenous colistimethate sodium. After ruling out other causes, a diagnosis of colistin-induced acquired Bartter syndrome was made. The patient required daily aggressive intravenous repletion of fluids and electrolytes. However, polyuria and metabolic abnormalities abated only after drug discontinuation.

Identifiants

pubmed: 32029515
pii: 13/2/e232630
doi: 10.1136/bcr-2019-232630
pmc: PMC7021182
pii:
doi:

Substances chimiques

colistinmethanesulfonic acid DL2R53P963
Colistin Z67X93HJG1

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Curr Opin Pediatr. 2017 Apr;29(2):179-186
pubmed: 27906863
Lancet Infect Dis. 2006 Sep;6(9):589-601
pubmed: 16931410
Crit Care. 2006 Feb;10(1):R27
pubmed: 16507149
Ren Fail. 2013;35(3):411-3
pubmed: 23342992
Nephron Physiol. 2006;104(2):p73-80
pubmed: 16785747
Nephrol Dial Transplant. 2012 Apr;27(4):1516-21
pubmed: 21865213
Int J Antimicrob Agents. 2005 Dec;26(6):504-7
pubmed: 16280245
Wien Klin Wochenschr. 2011 Sep;123(17-18):566-8
pubmed: 21739210
Lancet. 2000 Oct 7;356(9237):1255-9
pubmed: 11072960
Clin Infect Dis. 2009 Jun 15;48(12):1724-8
pubmed: 19438394
Drug Saf Case Rep. 2017 Dec;4(1):10
pubmed: 28699114
Am J Med Sci. 2005 Mar;329(3):144-9
pubmed: 15767821
Ann Intensive Care. 2011 May 25;1(1):14
pubmed: 21906345

Auteurs

Mohammad Tabish (M)

Medicine, All India Institute of Medical Sciences, New Delhi, India.

Manjit Mahendran (M)

Medicine, All India Institute of Medical Sciences, New Delhi, India.

Animesh Ray (A)

Medicine, All India Institute of Medical Sciences, New Delhi, India doctoranimeshray@gmail.com.

Naval Kishore Vikram (NK)

Medicine, All India Institute of Medical Sciences, New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH